Skip to Main Content

Paper Details

Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
Res Pract Thromb Haemost
2
2023
Author NameAffiliation
Michelle N GongMontefiore Medical Center
Michelle N GongAlbert Einstein College of Medicine
Matthew D NealUniversity of Pittsburgh
Matthew D Neal
  • 1 - 4

Datasets

Release 1.2